PAGE TOP
NEWS

NEWS

Series B Funding

Quantum Biosystems has raised 2.4 billion yen to accelerate the company’s DNA/RNA sequencer development as of February 6th. This Series B funding is from two new investors, Innovation Network Corporation of Japan(INCJ) and Mitsubishi UFJ Capital(MUCAP), and three existing investors, JAFCO, UTEC and Mizuho Capital.